Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marianne Camargo"'
Autor:
Zobair M Younossi, Vincent Wai‐Sun Wong, Quentin M. Anstee, Manuel Romero‐Gomez, Michael H. Trauner, Stephen A. Harrison, Eric J. Lawitz, Takeshi Okanoue, Marianne Camargo, Kathryn Kersey, Robert P. Myers, Zachary Goodman, Maria Stepanova
Publikováno v:
Hepatology Communications, Vol 4, Iss 11, Pp 1637-1650 (2020)
Fatigue and pruritus are common in patients with chronic liver diseases of all etiologies, but clinical awareness is mostly restricted to those with cholestatic liver diseases. We assessed the impact of fatigue and pruritus on patient‐reported outc
Externí odkaz:
https://doaj.org/article/9b10606dc65d41fca0697ee13b96e183
Autor:
Ioannis Konstantinidis, Shanti Patel, Marianne Camargo, Achint Patel, Priti Poojary, Steven G Coca, Girish N Nadkarni
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0176145 (2017)
Patients with kidney disease (KD) are at increased risk for cerebrovascular disease (CVD) and CVD patients with KD have worse outcomes. We aimed to determine the representation of KD patients in major randomized controlled trials (RCTs) of CVD interv
Externí odkaz:
https://doaj.org/article/7f0266904c7340bdac110424681ba189
Autor:
Cheng Yuan Peng, Hadas Dvory-Sobol, Sophia Lu, Peter Buggisch, Wan-Long Chuang, Anuj Gaggar, Christophe Moreno, Alessandra Mangia, Anu Osinusi, Luigi Biancone, Marianne Camargo, Meghan E. Sise, Tsung Hui Hu, Chen-Hua Liu, Brian J. Kirby, Wei Wen Su, Robert H. Hyland
Publikováno v:
American Journal of Gastroenterology. 116:1924-1928
Introduction We evaluated 8, 12, or 24 weeks of ledipasvir/sofosbuvir in patients with hepatitis C virus and end-stage renal disease undergoing dialysis. Methods Primary efficacy end point was sustained virologic response 12 weeks after treatment. Pr
Autor:
Sung-Gyun Kim, Nam Vo, Sang-Ho Lee, Dwarakanathan Ranganathan, Lesley Inker, Mohamed El-Shahawy, Terri Spinelli, Khushboo Sheth, Todd Devries, Marianne Camargo, Andrew King, Alan Glicklich, Muh Wong
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the developed world. Up to 40% of patients with IgAN are at risk of progressing to end-stage kidney disease (ESKD), with proteinuria being a strong predictor
Autor:
Richard A. Lafayette, Adeera Levin, Marianne Camargo, Andrew J. King, Hiddo J.L. Heerspink, Hong Zhang, Jonathan Barratt, Donald E. Kohan, Aland Glicklich
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims IgA nephropathy (IgAN) is the most common primary glomerulonephritis globally and an important cause of chronic kidney disease (CKD). Up to 40% of IgAN patients are at risk of progressing to end-stage kidney disease (ESKD) and pro
Autor:
Zobair M. Younossi, Quentin Anstee, Stephen Harrison, Michael Trauner, Eric Lawitz, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero Gomez, William Alazawi, Yevgeniy Gindin, Jing Zhu Zhou, Marianne Camargo, Kathryn Kersey, Chuhan Chung, Mani Subramanian, Robert Myers, Zachary Goodman, Rohit Loomba, William Rosenberg, Arun Sanyal
Publikováno v:
Journal of Hepatology. 73:S528-S530
Autor:
Zobair M. Younossi, Linda Henry, Vincent Wai-Sun Wong, Rob Myers, Manuel Romero-Gómez, Quentin M. Anstee, Michael Trauner, Eric Lawitz, Maria Stepanova, Marianne Camargo
Publikováno v:
Diabetes. 69
Background: ELF score is a non-invasive assessment for NASH fibrosis. We assessed associations between ELF, clinical outcomes and PROs in advanced NASH. Methods: NASH patients with advanced fibrosis (Stage ≥F3) were enrolled in 4 clinical trials of
Autor:
Quentin M. Anstee, Rob Myers, Vincent Wai-Sun Wong, Eric Lawitz, Zachary Goodman, Michael Trauner, Marianne Camargo, Zobair M. Younossi, Linda Henry, Maria Stepanova, Manuel Romero-Gómez
Publikováno v:
Diabetes. 69
Background: PROs of NASH patients have not been fully assessed. We assessed the impact of fatigue and pruritus on PROs of patients with advanced NASH. Methods: Baseline PROs including fatigue and pruritis (SF-36, CLDQ-NASH, EQ-5D, and WPAI instrument
Publikováno v:
Journal of Palliative Medicine. 20:1345-1351
Advance care planning (ACP) discussions often occur in the inpatient setting when patients are too ill to participate in decision making. Although the outpatient setting is the preferred time to begin these discussions, few physicians do so in practi
Autor:
Mazen Noureddin, Jörn M. Schattenberg, Javier Crespo, Masayuki Kurosaki, Chi-Yi Chen, Vincent Leroy, Manal Abdelmalek, Won Young Tak, Jacob George, Arun Shankar, Dora Ding, Marianne Camargo, Kathryn Kersey, Robert Myers, Stephen Harrison, Manuel Romero Gomez, Shiv Kumar Sarin, Zobair M. Younossi, Mary Rinella, Kathleen Corey
Publikováno v:
Journal of Hepatology. 73:S157-S158